Mary Jo White is an American attorney who served as the 31st Chair of the Securities and Exchange Commission (SEC) from 2013 to 2017. She was the United States Attorney for the Southern District of New York, serving from 1993 to 2002. On January 24, 2013, President Barack Obama nominated White to replace Elisse B. Walter as Chair of the U.S. Securities and Exchange Commission. She was confirmed by the Senate on April 8, 2013 and was sworn into office on April 10, 2013. On November 14, 2016, White announced she would step down from her SEC position at the end of the president’s term and is now the Senior Chair at Debevoise & Plimpton. She received a bachelor of arts from the College of William & Mary in 1970. She earned an master of arts in psychology in 1971 from The New School for Social Research and a Juris Doctor degree from Columbia Law School in 1974.
Edward White is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on both the biotechnology and the specialty pharmaceutical sectors. Mr. White’s expertise covers companies operating in the oncology, immune-oncology, infectious disease, and gastrointestinal sectors. Prior to working at H.C. Wainwright, Mr. White has worked as a Wall Street Healthcare Analyst, on both the buy-side and the sell-side, since 1996. Mr. White’s previous sell-side experience includes working for Fahnestock & Company (now Oppenheimer), Gerard, Klauer, Mattison & Company (now BMO Capital Markets), Deutsche Bank Securities, and a couple of boutique firms.